Clifford Chew, MD
Otolaryngology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 31 years
- Graduated 1995
Offices
1 location
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · Chinese Hospital · UCSF Health Hyde Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chew’s office at (415) 433-7945 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Chinese HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Chinese Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 104 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.64 to 1.61) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 766 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.13 (0.4 to 3.85) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.57 to 4.02) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.72 (0 to 18.54) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.1) · 478 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (160 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$134,884
Medicare paid this office $134,884 for 666 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 447 | $56,969 | $75 |
| New patient visit (30+ min) | 284 | $24,336 | $86 |
| Removal of impacted ear wax | 221 | $10,903 | $39 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $7,701 | $175 |
| Comprehensive hearing and speech recognition test | 173 | $5,331 | $30 |
See all 11 services
| Short return visit (20+ min) | 447 | $56,969 | $75 |
| New patient visit (30+ min) | 284 | $24,336 | $86 |
| Removal of impacted ear wax | 221 | $10,903 | $39 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $7,701 | $175 |
| Comprehensive hearing and speech recognition test | 173 | $5,331 | $30 |
| Diagnostic exam of voice box using an endoscope with mirror | 48 | $4,970 | $84 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $4,831 | $115 |
| Exam of ear using a microscope | 48 | $2,033 | $26 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,773 | $104 |
| Test to assess middle ear function | 110 | $1,554 | $14 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 28 | $1,262 | $45 |
Procedures Medicare counted
| Removal of skin lesions | 19 | More than 64% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 296 | 170 | 246 | 282 | 308 | 280 |
| Diagnostic exam of voice box using an endoscope with mirror | 119 | 64 | 95 | 124 | 91 | 59 |
| Diagnostic exam of nasal passages using an endoscope | 121 | 49 | 83 | 92 | 67 | 44 |
| Diagnostic exam of voice box using a flexible endoscope | 72 | 41 | 49 | 40 | 51 | 42 |
| Application of chemical to stop tissue regrowth in wound | 24 | – | 25 | 22 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
666 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 28% · Women 59% · Also on Medicaid 78% · Health risk score 1.33. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 27% · COPD 19% · Depression 18% · Heart failure 15% · Coronary heart disease 13% · Atrial fibrillation 11% · Cancer 10% · Dementia 9% · Stroke 8%.
The office billed $297,780, Medicare allowed $183,882 and paid $134,884; for 1,974 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 666 | 1,974 | 78 | 1.33 | $297,780 | $134,884 |
| 2023 | 749 | 2,248 | 78 | 1.24 | $344,301 | $167,413 |
| 2022 | 797 | 2,426 | 78 | 1.23 | $369,855 | $186,214 |
| 2021 | 748 | 2,299 | 77 | 1.16 | $351,358 | $189,677 |
| 2020 | 571 | 1,601 | 77 | 1.37 | $222,984 | $109,751 |
| 2019 | 957 | 2,972 | 78 | 1.37 | $467,437 | $242,845 |
| 2018 | 881 | 2,902 | 78 | 1.40 | $457,588 | $235,972 |
| 2017 | 828 | 2,494 | 77 | 1.41 | $417,385 | $218,803 |
| 2016 | 837 | 2,544 | 77 | 1.31 | $350,975 | $195,311 |
| 2015 | 848 | 2,750 | 77 | 1.39 | $369,530 | $205,786 |
| 2014 | 798 | 2,435 | 76 | 1.25 | $312,642 | $174,956 |
| 2013 | 814 | 2,518 | 76 | 1.25 | $312,731 | $184,748 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 498 | $69,806 | $80 |
| New patient visit (30+ min) | 289 | $25,323 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 63 | $12,550 | $187 |
| Removal of impacted ear wax | 233 | $12,545 | $41 |
| Diagnostic exam of voice box using an endoscope with mirror | 76 | $8,146 | $90 |
| Comprehensive hearing and speech recognition test | 220 | $7,445 | $33 |
| Diagnostic exam of voice box using a flexible endoscope | 34 | $4,786 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,530 | $115 |
| Test to assess middle ear function | 129 | $2,027 | $15 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 30 | $1,465 | $49 |
| Exam of ear using a microscope | 33 | $1,319 | $29 |
| Diagnostic exam of voice box using a flexible endoscope | 13 | $824 | $63 |
2022: 12 services
| Short return visit (20+ min) | 522 | $74,897 | $82 |
| New patient visit (30+ min) | 338 | $31,359 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 83 | $17,582 | $191 |
| Removal of impacted ear wax | 210 | $11,941 | $42 |
| Diagnostic exam of voice box using an endoscope with mirror | 96 | $11,417 | $92 |
| Comprehensive hearing and speech recognition test | 198 | $6,773 | $33 |
| Diagnostic exam of voice box using a flexible endoscope | 30 | $5,140 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,395 | $121 |
| Test to assess middle ear function | 154 | $2,459 | $16 |
| Application of chemical to stop tissue regrowth in wound | 16 | $2,008 | $91 |
| Exam of ear using a microscope | 45 | $1,815 | $29 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 42 | $1,804 | $43 |
2021: 13 services
| Short return visit (20+ min) | 482 | $71,149 | $83 |
| New patient visit (30+ min) | 314 | $30,520 | $97 |
| Diagnostic exam of nasal passages using an endoscope | 78 | $16,830 | $203 |
| Removal of impacted ear wax | 181 | $10,373 | $42 |
| Diagnostic exam of voice box using an endoscope with mirror | 80 | $8,661 | $91 |
| Comprehensive hearing and speech recognition test | 221 | $8,172 | $35 |
| Diagnostic exam of voice box using a flexible endoscope | 23 | $4,212 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,893 | $122 |
| Test to assess middle ear function | 171 | $2,746 | $16 |
| Application of chemical to stop tissue regrowth in wound | 12 | $2,262 | $90 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 35 | $1,681 | $48 |
| Exam of ear using a microscope | 34 | $1,268 | $28 |
| Diagnostic exam of voice box using a flexible endoscope | 15 | $950 | $63 |
2020: 12 services
| Short return visit (20+ min) | 376 | $38,770 | $64 |
| New patient visit (30+ min) | 186 | $15,003 | $81 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $9,343 | $191 |
| Removal of impacted ear wax | 136 | $6,660 | $39 |
| Diagnostic exam of voice box using an endoscope with mirror | 54 | $5,228 | $82 |
| Comprehensive hearing and speech recognition test | 139 | $4,742 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,770 | $126 |
| Diagnostic exam of voice box using a flexible endoscope | 20 | $2,521 | $120 |
| Test to assess middle ear function | 104 | $1,518 | $14 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $1,272 | $64 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 26 | $1,019 | $39 |
| Exam of ear using a microscope | 26 | $991 | $29 |
2019: 14 services
| Short return visit (20+ min) | 599 | $71,634 | $66 |
| New patient visit (30+ min) | 381 | $33,795 | $89 |
| Diagnostic exam of nasal passages using an endoscope | 103 | $23,917 | $198 |
| Removal of impacted ear wax | 223 | $11,917 | $40 |
| Comprehensive hearing and speech recognition test | 325 | $11,603 | $34 |
| Diagnostic exam of voice box using an endoscope with mirror | 99 | $9,389 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,652 | $119 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $4,602 | $110 |
| Test to assess middle ear function | 178 | $2,514 | $14 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 54 | $2,367 | $44 |
| Exam of ear using a microscope | 48 | $1,952 | $29 |
| Diagnostic exam of voice box using a flexible endoscope | 30 | $1,847 | $62 |
| Application of chemical to stop tissue regrowth in wound | 15 | $1,798 | $75 |
| Return visit (30+ min) | 21 | $1,650 | $79 |
2018: 15 services
| Short return visit (20+ min) | 559 | $65,278 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 96 | $26,534 | $207 |
| New patient visit (30+ min) | 309 | $26,464 | $86 |
| Removal of impacted ear wax | 187 | $9,865 | $40 |
| Diagnostic exam of voice box using an endoscope with mirror | 107 | $9,825 | $77 |
| Comprehensive hearing and speech recognition test | 280 | $9,520 | $33 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $6,017 | $106 |
| Return visit (30+ min) | 63 | $5,944 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,145 | $121 |
| Test to assess middle ear function | 188 | $2,494 | $13 |
| Application of chemical to stop tissue regrowth in wound | 22 | $2,410 | $80 |
| Exam of ear using a microscope | 49 | $2,332 | $28 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 49 | $2,332 | $48 |
| New patient visit (45+ min) | 15 | $2,061 | $137 |
| Diagnostic exam of voice box using a flexible endoscope | 17 | $1,107 | $61 |
2017: 14 services
| Short return visit (20+ min) | 507 | $57,476 | $65 |
| New patient visit (30+ min) | 303 | $28,149 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 93 | $25,674 | $212 |
| Removal of impacted ear wax | 155 | $8,761 | $43 |
| Comprehensive hearing and speech recognition test | 252 | $8,620 | $34 |
| Diagnostic exam of voice box using an endoscope with mirror | 80 | $7,843 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 42 | $5,609 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $5,236 | $122 |
| Test to assess middle ear function | 190 | $2,620 | $14 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 40 | $1,956 | $49 |
| Diagnostic exam of voice box using a flexible endoscope | 28 | $1,773 | $63 |
| Application of chemical to stop tissue regrowth in wound | 19 | $1,755 | $80 |
| Return visit (30+ min) | 17 | $1,621 | $95 |
| Exam of ear using a microscope | 35 | $1,416 | $30 |
2016: 14 services
| Short return visit (20+ min) | 538 | $58,277 | $66 |
| New patient visit (30+ min) | 291 | $26,678 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 85 | $21,489 | $219 |
| Removal of impacted ear wax | 162 | $9,243 | $44 |
| Diagnostic exam of voice box using an endoscope with mirror | 85 | $8,419 | $84 |
| Comprehensive hearing and speech recognition test | 235 | $8,408 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $6,113 | $122 |
| Diagnostic exam of voice box using a flexible endoscope | 35 | $4,841 | $110 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 11 | $3,855 | $350 |
| Diagnostic exam of voice box using a flexible endoscope | 38 | $2,906 | $73 |
| Test to assess middle ear function | 166 | $2,347 | $14 |
| Exam of ear using a microscope | 35 | $1,506 | $31 |
| Return visit (30+ min) | 15 | $1,474 | $87 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 24 | $1,135 | $47 |
2015: 14 services
| Short return visit (20+ min) | 515 | $60,435 | $65 |
| New patient visit (30+ min) | 300 | $25,833 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 78 | $21,841 | $216 |
| Removal of impacted ear wax | 145 | $8,661 | $45 |
| Comprehensive hearing and speech recognition test | 240 | $8,106 | $32 |
| Diagnostic exam of voice box using an endoscope with mirror | 71 | $7,380 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $6,629 | $123 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $5,151 | $110 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $3,696 | $72 |
| Return visit (30+ min) | 29 | $2,960 | $90 |
| Test to assess middle ear function | 199 | $2,742 | $13 |
| Application of chemical to stop tissue regrowth in wound | 19 | $2,023 | $81 |
| Exam of ear using a microscope | 40 | $1,492 | $30 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 15 | $769 | $51 |
2014: 17 services
| Short return visit (20+ min) | 471 | $51,494 | $64 |
| New patient visit (30+ min) | 289 | $25,768 | $89 |
| Diagnostic exam of nasal passages using an endoscope | 68 | $19,430 | $214 |
| Diagnostic exam of voice box using a flexible endoscope | 69 | $9,102 | $111 |
| Removal of impacted ear wax | 142 | $8,001 | $45 |
| Comprehensive hearing and speech recognition test | 207 | $7,065 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $6,235 | $122 |
| Diagnostic exam of voice box using an endoscope with mirror | 53 | $5,308 | $83 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 12 | $4,027 | $336 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $2,887 | $72 |
| Application of chemical to stop tissue regrowth in wound | 22 | $2,367 | $76 |
| Return visit (30+ min) | 16 | $1,862 | $98 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 35 | $1,769 | $51 |
| Test to assess middle ear function | 103 | $1,423 | $14 |
| Exam of ear using a microscope | 29 | $1,135 | $31 |
| Short return visit | 15 | $1,037 | $37 |
| New patient visit (15+ min) | 12 | $778 | $65 |
2013: 16 services
| Short return visit (20+ min) | 456 | $49,633 | $66 |
| New patient visit (30+ min) | 328 | $31,428 | $96 |
| Diagnostic exam of nasal passages using an endoscope | 100 | $29,491 | $222 |
| Comprehensive hearing and speech recognition test | 255 | $8,856 | $33 |
| Diagnostic exam of voice box using a flexible endoscope | 69 | $8,723 | $115 |
| Removal of impacted ear wax | 134 | $8,077 | $49 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,659 | $119 |
| Return visit (30+ min) | 41 | $4,590 | $96 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 11 | $3,817 | $347 |
| Diagnostic exam of voice box using an endoscope with mirror | 35 | $3,648 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 36 | $3,016 | $72 |
| Test to assess middle ear function | 170 | $2,227 | $13 |
| Application of chemical to stop tissue regrowth in wound | 21 | $1,880 | $78 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 29 | $1,469 | $51 |
| Short return visit | 14 | $933 | $39 |
| Exam of ear using a microscope | 20 | $743 | $32 |
Medicaid work
$58,311 in 2024
Medicaid paid $58,311 for 1,088 billed services this clinician did in 2024, up to 80 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 571 | $27,826 |
| New patient visit (30+ min) | 329 | $24,618 |
| Comprehensive audiometry threshold evaluation and speech recognition | 89 | $2,879 |
| Removal of impacted ear wax | 62 | $2,357 |
| Binocular microscopy | 25 | $574 |
| TYMPANOMETRY | 12 | $59 |
| 2024 | 1,088 | 6 | 80 | $58,311 |
| 2023 | 1,075 | 5 | 69 | $56,050 |
| 2022 | 586 | 6 | 42 | $19,499 |
| 2021 | 732 | 7 | 43 | $31,179 |
| 2020 | 285 | 3 | 33 | $6,419 |
| 2019 | 334 | 3 | 34 | $2,075 |
| 2018 | 169 | 2 | 18 | $691 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 312 | $25,832 |
| Short return visit (20+ min) | 582 | $21,222 |
| Comprehensive audiometry threshold evaluation and speech recognition | 110 | $4,941 |
| Removal of impacted ear wax | 59 | $2,849 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $1,206 |
2022
| New patient visit (30+ min) | 142 | $9,716 |
| Short return visit (20+ min) | 374 | $8,260 |
| Comprehensive audiometry threshold evaluation and speech recognition | 28 | $796 |
| Removal of impacted ear wax | 16 | $723 |
| TYMPANOMETRY | 14 | $4 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $0 |
2021
| New patient visit (30+ min) | 216 | $18,622 |
| Short return visit (20+ min) | 416 | $9,599 |
| Removal of impacted ear wax | 39 | $1,459 |
| Comprehensive audiometry threshold evaluation and speech recognition | 25 | $811 |
| Diagnostic indirect laryngoscopy | 12 | $668 |
| TYMPANOMETRY | 12 | $20 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $0 |
2020
| Short return visit (20+ min) | 225 | $3,766 |
| New patient visit (30+ min) | 46 | $2,136 |
| Comprehensive audiometry threshold evaluation and speech recognition | 14 | $517 |
2019
| New patient visit (30+ min) | 68 | $995 |
| Short return visit (20+ min) | 254 | $934 |
| Comprehensive audiometry threshold evaluation and speech recognition | 12 | $146 |
2018
| Short return visit (20+ min) | 155 | $488 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 14 | $204 |
Drugs they prescribed that Part D paid
$61,854
Pharmacies billed $61,854 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 1,944) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
1,866 generic and 78 brand-name prescriptions · $61,854 in drug cost · 186 antibiotic prescriptions to 146 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 109 | $10,103 | $93 |
| Ofloxacin | 129 | $8,248 | $64 |
| Fluocinolone Acetonide Oil | 198 | $6,687 | $34 |
| Triamcinolone Acetonide | 178 | $3,826 | $21 |
| Fluticasone Propionate | 308 | $3,025 | $10 |
See all 29 drugs
| Ciprofloxacin-Dexamethasone | 109 | $10,103 | $93 |
| Ofloxacin | 129 | $8,248 | $64 |
| Fluocinolone Acetonide Oil | 198 | $6,687 | $34 |
| Triamcinolone Acetonide | 178 | $3,826 | $21 |
| Fluticasone Propionate | 308 | $3,025 | $10 |
| Neomycin-Polymyxin-Hc | 44 | $2,062 | $47 |
| Azelastine | 71 | $1,494 | $21 |
| Dexamethasone | 79 | $1,175 | $15 |
| Clotrimazole | 36 | $1,141 | $32 |
| Ipratropium | 39 | $995 | $26 |
| Amoxicillin-Clavulanate Potass | 101 | $604 | $6 |
| Famotidine | 32 | $597 | $19 |
| Chlorhexidine Gluconate | 96 | $504 | $5 |
| Mupirocin | 72 | $342 | $5 |
| Fluocinonide | 18 | $314 | $17 |
| Gabapentin | 51 | $305 | $6 |
| Montelukast | 23 | $250 | $11 |
| Pantoprazole | 25 | $189 | $8 |
| Omeprazole | 14 | $123 | $9 |
| Naproxen | 21 | $116 | $6 |
| Trazodone | 16 | $112 | $7 |
| Doxycycline Hyclate | 13 | $90 | $7 |
| Prednisone | 34 | $77 | $2 |
| Methylprednisolone | 17 | $71 | $4 |
| Meclizine | 17 | $63 | $4 |
| Amoxicillin | 38 | $54 | $1 |
| Acetaminophen-Codeine | 11 | $47 | $4 |
| Ibuprofen | 11 | $41 | $4 |
| Azithromycin | 13 | $23 | $2 |
Year by year
| 2024 | 1,944 | 794 | 1% (15) | 4% | $61,854 |
| 2023 | 1,986 | 740 | 1% (27) | None | $87,464 |
| 2022 | 1,927 | 754 | 1% (27) | 3% | $77,304 |
| 2021 | 1,920 | 682 | 2% (28) | 3% | $64,089 |
| 2020 | 1,612 | 563 | 1% (17) | 4% | $59,521 |
| 2019 | 1,955 | 782 | 2% (39) | 6% | $88,489 |
| 2018 | 1,739 | 603 | 3% (51) | 6% | $89,711 |
| 2017 | 1,555 | 536 | 2% (24) | 7% | $76,225 |
| 2016 | 1,632 | 630 | 2% (31) | 13% | $69,165 |
| 2015 | 1,692 | 638 | 3% (44) | 11% | $68,623 |
| 2014 | 1,454 | 577 | 2% (35) | None | $66,490 |
| 2013 | 1,460 | 590 | 3% (39) | 14% | $59,383 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Ofloxacin | 143 | $11,205 | $78 |
| Xhance | 14 | $10,320 | $737 |
| Fluocinolone Acetonide Oil | 179 | $10,254 | $57 |
| Fluticasone Propionate | 286 | $6,030 | $21 |
| Neomycin-Polymyxin-Hc | 89 | $5,640 | $63 |
| Triamcinolone Acetonide | 202 | $5,367 | $27 |
| Ciprofloxacin-Dexamethasone | 36 | $5,354 | $149 |
| Azelastine | 85 | $3,541 | $42 |
| Clotrimazole | 41 | $2,093 | $51 |
| Ipratropium | 52 | $1,702 | $33 |
| Famotidine | 34 | $1,318 | $39 |
| Dexamethasone | 67 | $1,317 | $20 |
| Amoxicillin-Clavulanate Potass | 74 | $1,033 | $14 |
| Mupirocin | 87 | $810 | $9 |
| Montelukast | 37 | $717 | $19 |
| Chlorhexidine Gluconate | 108 | $673 | $6 |
| Doxycycline Hyclate | 32 | $613 | $19 |
| Gabapentin | 41 | $521 | $13 |
| Pantoprazole | 27 | $468 | $17 |
| Omeprazole | 20 | $406 | $20 |
| Fluocinonide | 15 | $398 | $27 |
| Ibuprofen | 24 | $216 | $9 |
| Amoxicillin | 48 | $144 | $3 |
| Azithromycin | 24 | $125 | $5 |
| Acetaminophen-Codeine | 20 | $97 | $5 |
| Meclizine | 11 | $78 | $7 |
| Cephalexin | 16 | $58 | $4 |
| Prednisone | 15 | $54 | $4 |
2022: 33 drugs
| Ofloxacin | 163 | $12,425 | $76 |
| Fluocinolone Acetonide Oil | 124 | $8,214 | $66 |
| Ciprofloxacin-Dexamethasone | 40 | $6,759 | $169 |
| Triamcinolone Acetonide | 166 | $5,485 | $33 |
| Neomycin-Polymyxin-Hc | 73 | $4,740 | $65 |
| Fluticasone Propionate | 278 | $3,791 | $14 |
| Azelastine | 79 | $3,161 | $40 |
| Clotrimazole | 45 | $2,023 | $45 |
| Ipratropium | 46 | $1,758 | $38 |
| Fluocinolone Acetonide | 14 | $1,459 | $104 |
| Amoxicillin-Clavulanate Potass | 115 | $1,108 | $10 |
| Montelukast | 55 | $1,083 | $20 |
| Mupirocin | 68 | $755 | $11 |
| Dexamethasone | 55 | $722 | $13 |
| Chlorhexidine Gluconate | 97 | $619 | $6 |
| Fluocinonide | 19 | $577 | $30 |
| Fluconazole | 12 | $518 | $43 |
| Dexamethasone Sodium Phosphate | 11 | $425 | $39 |
| Doxycycline Hyclate | 18 | $363 | $20 |
| Gabapentin | 60 | $355 | $6 |
| Famotidine | 12 | $334 | $28 |
| Pantoprazole | 17 | $300 | $18 |
| Omeprazole | 12 | $180 | $15 |
| Amoxicillin | 60 | $171 | $3 |
| Trazodone | 15 | $148 | $10 |
| Azithromycin | 18 | $136 | $8 |
| Ibuprofen | 22 | $134 | $6 |
| Meclizine | 21 | $113 | $5 |
| Clindamycin | 12 | $99 | $8 |
| Naproxen | 15 | $96 | $6 |
| Acetaminophen-Codeine | 23 | $93 | $4 |
| Prednisone | 21 | $79 | $4 |
| Cephalexin | 20 | $71 | $4 |
2021: 27 drugs
| Ofloxacin | 183 | $12,876 | $70 |
| Fluocinolone Acetonide Oil | 115 | $6,394 | $56 |
| Triamcinolone Acetonide | 163 | $6,191 | $38 |
| Fluticasone Propionate | 316 | $4,077 | $13 |
| Neomycin-Polymyxin-Hc | 60 | $3,587 | $60 |
| Ciprofloxacin-Dexamethasone | 18 | $3,439 | $191 |
| Fluocinolone Acetonide | 37 | $2,845 | $77 |
| Azelastine | 88 | $2,797 | $32 |
| Dexamethasone | 118 | $1,579 | $13 |
| Ipratropium | 32 | $1,530 | $48 |
| Clotrimazole | 35 | $1,416 | $40 |
| Fluocinonide | 25 | $1,007 | $40 |
| Amoxicillin-Clavulanate Potass | 78 | $781 | $10 |
| Montelukast | 47 | $594 | $13 |
| Mupirocin | 59 | $507 | $9 |
| Chlorhexidine Gluconate | 82 | $456 | $6 |
| Omeprazole | 35 | $429 | $12 |
| Gabapentin | 44 | $261 | $6 |
| Amoxicillin | 60 | $226 | $4 |
| Pantoprazole | 15 | $191 | $13 |
| Clindamycin | 17 | $176 | $10 |
| Ibuprofen | 34 | $161 | $5 |
| Prednisone | 21 | $75 | $4 |
| Meclizine | 15 | $74 | $5 |
| Ciprofloxacin | 11 | $70 | $6 |
| Cephalexin | 17 | $69 | $4 |
| Acetaminophen-Codeine | 19 | $59 | $3 |
2020: 30 drugs
| Ofloxacin | 144 | $9,835 | $68 |
| Ciprodex | 33 | $8,969 | $272 |
| Fluocinolone Acetonide Oil | 85 | $6,965 | $82 |
| Triamcinolone Acetonide | 140 | $4,815 | $34 |
| Fluticasone Propionate | 274 | $3,936 | $14 |
| Fluocinolone Acetonide | 36 | $3,149 | $87 |
| Clotrimazole | 27 | $2,910 | $108 |
| Neomycin-Polymyxin-Hc | 35 | $2,352 | $67 |
| Azelastine | 62 | $2,135 | $34 |
| Fluocinonide | 33 | $1,679 | $51 |
| Dexamethasone | 97 | $1,468 | $15 |
| Neomycin-Polymyxin-Hydrocort | 12 | $984 | $82 |
| Amoxicillin-Clavulanate Potass | 66 | $616 | $9 |
| Valacyclovir | 15 | $566 | $38 |
| Ipratropium | 11 | $476 | $43 |
| Montelukast | 42 | $432 | $10 |
| Olopatadine | 12 | $329 | $27 |
| Mupirocin | 37 | $303 | $8 |
| Gabapentin | 45 | $279 | $6 |
| Pantoprazole | 30 | $274 | $9 |
| Omeprazole | 37 | $250 | $7 |
| Famotidine | 11 | $183 | $17 |
| Ibuprofen | 37 | $139 | $4 |
| Clindamycin | 17 | $137 | $8 |
| Chlorhexidine Gluconate | 29 | $134 | $5 |
| Amoxicillin | 49 | $127 | $3 |
| Azithromycin | 18 | $80 | $4 |
| Meclizine | 12 | $78 | $7 |
| Prednisone | 16 | $58 | $4 |
| Cephalexin | 11 | $33 | $3 |
2019: 30 drugs
| Ciprodex | 91 | $22,307 | $245 |
| Ofloxacin | 131 | $12,387 | $95 |
| Fluocinolone Acetonide Oil | 69 | $8,399 | $122 |
| Triamcinolone Acetonide | 193 | $6,324 | $33 |
| Fluticasone Propionate | 337 | $5,034 | $15 |
| Fluocinonide | 52 | $3,151 | $61 |
| Clotrimazole | 29 | $2,974 | $103 |
| Azelastine | 61 | $2,340 | $38 |
| Neomycin-Polymyxin-Hc | 37 | $2,252 | $61 |
| Dexamethasone | 106 | $2,149 | $20 |
| Fluocinolone Acetonide | 16 | $1,685 | $105 |
| Amoxicillin-Clavulanate Potass | 104 | $1,362 | $13 |
| Montelukast | 49 | $1,120 | $23 |
| Olopatadine | 16 | $822 | $51 |
| Mupirocin | 83 | $787 | $9 |
| Gabapentin | 63 | $645 | $10 |
| Nystatin | 15 | $503 | $34 |
| Omeprazole | 25 | $473 | $19 |
| Pantoprazole | 25 | $434 | $17 |
| Chlorhexidine Gluconate | 52 | $314 | $6 |
| Methylprednisolone | 20 | $292 | $15 |
| Ibuprofen | 40 | $270 | $7 |
| Prednisone | 47 | $203 | $4 |
| Azithromycin | 18 | $179 | $10 |
| Amoxicillin | 43 | $147 | $3 |
| Lorazepam | 21 | $140 | $7 |
| Hydrocodone-Acetaminophen | 20 | $136 | $7 |
| Ciprofloxacin | 11 | $116 | $11 |
| Cephalexin | 17 | $82 | $5 |
| Acetaminophen-Codeine | 18 | $75 | $4 |
2018: 28 drugs
| Ofloxacin | 130 | $23,727 | $183 |
| Ciprodex | 63 | $16,184 | $257 |
| Fluocinolone Acetonide Oil | 50 | $7,031 | $141 |
| Triamcinolone Acetonide | 169 | $6,953 | $41 |
| Fluocinonide | 74 | $4,880 | $66 |
| Clotrimazole | 58 | $4,676 | $81 |
| Fluticasone Propionate | 315 | $4,143 | $13 |
| Neomycin-Polymyxin-Hc | 44 | $2,738 | $62 |
| Azelastine | 66 | $2,607 | $40 |
| Amoxicillin-Clavulanate Potass | 87 | $1,376 | $16 |
| Dexamethasone | 75 | $1,348 | $18 |
| Neomycin-Polymyxin-Hydrocort | 13 | $891 | $69 |
| Nystatin | 24 | $818 | $34 |
| Montelukast | 43 | $778 | $18 |
| Valacyclovir | 13 | $595 | $46 |
| Mupirocin | 55 | $553 | $10 |
| Gabapentin | 53 | $527 | $10 |
| Lidocaine Hcl Viscous | 15 | $222 | $15 |
| Pantoprazole | 14 | $200 | $14 |
| Prednisone | 25 | $135 | $5 |
| Chlorhexidine Gluconate | 32 | $129 | $4 |
| Omeprazole | 18 | $120 | $7 |
| Amoxicillin | 35 | $116 | $3 |
| Acetaminophen-Codeine | 26 | $97 | $4 |
| Hydrocodone-Acetaminophen | 25 | $95 | $4 |
| Azithromycin | 17 | $94 | $6 |
| Ibuprofen | 15 | $66 | $4 |
| Lorazepam | 21 | $64 | $3 |
2017: 25 drugs
| Ofloxacin | 141 | $20,805 | $148 |
| Ciprodex | 38 | $7,662 | $202 |
| Fluocinolone Acetonide Oil | 51 | $7,614 | $149 |
| Triamcinolone Acetonide | 136 | $5,813 | $43 |
| Nasonex | 14 | $5,506 | $393 |
| Fluocinonide | 69 | $4,265 | $62 |
| Fluticasone Propionate | 294 | $4,116 | $14 |
| Azelastine | 82 | $3,933 | $48 |
| Clotrimazole | 38 | $2,805 | $74 |
| Neomycin-Polymyxin-Hc | 47 | $2,515 | $54 |
| Amoxicillin-Clavulanate Potass | 97 | $1,396 | $14 |
| Dexamethasone | 82 | $1,239 | $15 |
| Gabapentin | 72 | $851 | $12 |
| Montelukast | 34 | $592 | $17 |
| Mupirocin | 58 | $480 | $8 |
| Nystatin | 11 | $379 | $34 |
| Pantoprazole | 19 | $176 | $9 |
| Ciprofloxacin | 15 | $165 | $11 |
| Prednisone | 35 | $160 | $5 |
| Omeprazole | 12 | $130 | $11 |
| Amoxicillin | 28 | $109 | $4 |
| Cephalexin | 20 | $84 | $4 |
| Chlorhexidine Gluconate | 17 | $81 | $5 |
| Azithromycin | 13 | $76 | $6 |
| Hydrocodone-Acetaminophen | 16 | $44 | $3 |
2016: 29 drugs
| Ciprodex | 38 | $9,378 | $247 |
| Nasonex | 30 | $8,732 | $291 |
| Fluocinolone Acetonide Oil | 40 | $6,472 | $162 |
| Fluocinonide | 84 | $5,623 | $67 |
| Triamcinolone Acetonide | 128 | $5,511 | $43 |
| Azelastine | 90 | $5,335 | $59 |
| Neomycin-Polymyxin-Hc | 82 | $4,233 | $52 |
| Ofloxacin | 120 | $3,468 | $29 |
| Fluticasone Propionate | 290 | $3,079 | $11 |
| Clotrimazole | 29 | $2,127 | $73 |
| Amoxicillin-Clavulanate Potass | 128 | $2,043 | $16 |
| Dexamethasone | 53 | $1,263 | $24 |
| Neomycin-Polymyxin-Hydrocort | 17 | $892 | $52 |
| Valacyclovir | 20 | $650 | $33 |
| Gabapentin | 32 | $469 | $15 |
| Mupirocin | 41 | $330 | $8 |
| Prednisone | 40 | $313 | $8 |
| Ciprofloxacin | 32 | $238 | $7 |
| Pantoprazole | 18 | $198 | $11 |
| Meclizine | 13 | $148 | $11 |
| Amoxicillin | 34 | $124 | $4 |
| Azithromycin | 23 | $124 | $5 |
| Omeprazole | 22 | $116 | $5 |
| Hydrocodone-Acetaminophen | 15 | $103 | $7 |
| Clindamycin | 11 | $100 | $9 |
| Levofloxacin | 13 | $84 | $6 |
| Acetaminophen-Codeine | 16 | $79 | $5 |
| Cephalexin | 21 | $62 | $3 |
| Naproxen | 12 | $51 | $4 |
2015: 29 drugs
| Ofloxacin | 129 | $9,767 | $76 |
| Nasonex | 35 | $8,827 | $252 |
| Ciprodex | 36 | $6,309 | $175 |
| Triamcinolone Acetonide | 109 | $5,679 | $52 |
| Fluocinonide | 93 | $4,986 | $54 |
| Fluticasone Propionate | 393 | $4,427 | $11 |
| Fluocinolone Acetonide Oil | 26 | $4,365 | $168 |
| Azelastine | 37 | $2,359 | $64 |
| Amoxicillin-Clavulanate Potass | 127 | $2,210 | $17 |
| Neomycin-Polymyxin-Hydrocort | 40 | $1,756 | $44 |
| Dexamethasone | 57 | $1,648 | $29 |
| Clotrimazole | 23 | $1,602 | $70 |
| Nystatin | 33 | $1,243 | $38 |
| Neomycin-Polymyxin-Hc | 27 | $998 | $37 |
| Gabapentin | 46 | $493 | $11 |
| Valacyclovir | 19 | $435 | $23 |
| Mupirocin | 36 | $359 | $10 |
| Pantoprazole | 32 | $344 | $11 |
| Montelukast | 20 | $242 | $12 |
| Hydrocodone-Acetaminophen | 22 | $201 | $9 |
| Prednisone | 35 | $165 | $5 |
| Ciprofloxacin | 21 | $155 | $7 |
| Omeprazole | 25 | $152 | $6 |
| Meclizine | 15 | $142 | $9 |
| Cephalexin | 32 | $124 | $4 |
| Chlorhexidine Gluconate | 23 | $120 | $5 |
| Azithromycin | 24 | $120 | $5 |
| Acetaminophen-Codeine | 22 | $113 | $5 |
| Amoxicillin | 23 | $70 | $3 |
2014: 29 drugs
| Ciprodex | 38 | $6,044 | $159 |
| Triamcinolone Acetonide | 92 | $5,381 | $58 |
| Azelastine | 64 | $5,130 | $80 |
| Patanase | 21 | $4,955 | $236 |
| Nasonex | 24 | $4,721 | $197 |
| Fluticasone Propionate | 245 | $4,613 | $19 |
| Fluocinonide | 76 | $4,183 | $55 |
| Ofloxacin | 132 | $4,115 | $31 |
| Fluocinolone Acetonide Oil | 23 | $4,092 | $178 |
| Amox Tr-Potassium Clavulanate | 118 | $2,442 | $21 |
| Astepro | 16 | $2,115 | $132 |
| Nystatin | 32 | $1,198 | $37 |
| Dexamethasone | 34 | $691 | $20 |
| Neomycin-Polymyxin-Hydrocort | 23 | $541 | $24 |
| Gabapentin | 55 | $535 | $10 |
| Clotrimazole | 11 | $404 | $37 |
| Montelukast | 15 | $371 | $25 |
| Neomycin-Polymyxin-Hc | 13 | $303 | $23 |
| Pantoprazole | 22 | $277 | $13 |
| Hydrocodone-Acetaminophen | 30 | $233 | $8 |
| Meclizine | 19 | $212 | $11 |
| Omeprazole | 29 | $208 | $7 |
| Azithromycin | 24 | $195 | $8 |
| Ciprofloxacin | 26 | $189 | $7 |
| Prednisone | 32 | $165 | $5 |
| Amoxicillin | 32 | $152 | $5 |
| Mupirocin | 11 | $150 | $14 |
| Cephalexin | 27 | $120 | $4 |
| Ibuprofen | 12 | $51 | $4 |
2013: 28 drugs
| Fluticasone Propionate | 281 | $7,271 | $26 |
| Ciprodex | 35 | $5,927 | $169 |
| Triamcinolone Acetonide | 89 | $4,815 | $54 |
| Nasonex | 32 | $4,557 | $142 |
| Fluocinonide | 80 | $4,392 | $55 |
| Patanase | 27 | $4,207 | $156 |
| Azelastine | 55 | $3,871 | $70 |
| Ofloxacin | 91 | $2,384 | $26 |
| Nystatin | 44 | $2,066 | $47 |
| Amox Tr-Potassium Clavulanate | 93 | $2,061 | $22 |
| Fluocinolone Acetonide Oil | 16 | $1,780 | $111 |
| Neomycin-Polymyxin-Hc | 41 | $1,008 | $25 |
| Valacyclovir | 23 | $1,000 | $43 |
| Gabapentin | 59 | $849 | $14 |
| Dexamethasone | 43 | $757 | $18 |
| Montelukast | 16 | $663 | $41 |
| Methylprednisolone | 17 | $538 | $32 |
| Mupirocin | 20 | $311 | $16 |
| Azithromycin | 32 | $298 | $9 |
| Hydrocodone-Acetaminophen | 38 | $264 | $7 |
| Omeprazole | 27 | $259 | $10 |
| Pantoprazole | 15 | $207 | $14 |
| Amoxicillin | 34 | $163 | $5 |
| Chlorhexidine Gluconate | 22 | $159 | $7 |
| Ciprofloxacin | 20 | $157 | $8 |
| Prednisone | 37 | $133 | $4 |
| Cephalexin | 20 | $98 | $5 |
| Clindamycin | 12 | $86 | $7 |
Money from drug and device companies
$129 in 2024
| 2024 | 1 | 1 | None | $129 |
| 2023 | 2 | 2 | None | $272 |
| 2021 | 1 | 1 | None | $35 |
| 2019 | 2 | 2 | None | $131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $129 | 1 payment
|
See the published payment
| Janssen Pharmaceuticals | Meals · 2024-05-02 | Xarelto | $129 |
See earlier years (2023, 2021, 2019)
2023: $272
| Hologic Sales and Service | Coolseal Generator | $151 | 1 payment
|
| Gilead Sciences | Vemlidy | $121 | 1 payment
|
2021: $35
| Stryker | Clarifix Cryotherapy Device | $35 | 1 payment
|
2019: $131
| Gilead Sciences | None | $110 | 1 payment
|
| Intersect ENT | Propel | $22 | 1 payment
|
Professional record
- NPI
- 1215036066
- Licence
- CA A624720
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 9864433
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 929 Clay St, Suite 501, San Francisco, CA, 94108
- NPI first listed
- 2006-09-21
- NPI last updated
- 2011-11-22
This is when the NPI record was last certified, not a medical board exam.